VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CYRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CYRXCryoport, Inc.
$17.49$882M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCYRXBalance Sheet

Cryoport, Inc. (CYRX) Balance Sheet

23Y historyFree accessUpdated daily

The balance sheet has been fortified to a current ratio of 2.08 via a major equity injection, but the equity base of $490.7 million is constructed entirely on external financing, not operational profits, as evidenced by the accumulated deficit of -$707.7 million.

Income StatementBalance SheetCash FlowRatios

CYRX Balance Sheet

Annual statement

CYRX Balance Sheet

Cryoport, Inc. (CYRX) balance sheet — 23-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10Mar'09Mar'08Mar'07Mar'06Mar'05Mar'05
Total Current Assets460.2M476.17M341.57M535.11M604.18M693.52M147.16M102.97M51.77M17.3M6.1M6.21M2.16M1.11M958.3K5.13M10M3.91M1.54M3.35M435.89K292.85K966.84K966.84K
Cash & Short-Term Investments396.69M411.21M261.75M456.75M523.32M628.8M93.32M94.3M47.26M15.04M4.52M5.25M1.41M369.58K563.1K4.62M9.28M3.63M776.17K2.79M264.39K41.39K720.2K720.2K
Cash Only269.27M250.49M45.29M46.35M36.59M139.1M36.87M47.23M37.33M15.04M5.25M5.25M1.41M369.58K563.1K4.62M9.28M3.63M776.17K2.79M264.39K41.39K720.2K720.2K
Short-Term Investments127.43M160.71M216.46M410.41M486.73M489.7M56.44M47.06M9.93M0-2.79B0000000000000
Accounts Receivable36.45M33.36M45.78M42.07M43.86M39.41M31.38M7.1M3.54M1.63M1.2M616.78K589.7K515.83K217.1K146.12K55.79K78.04K4.82K32.59K10.17K47.83K44.55K44.55K
Days Sales Outstanding70.3469.1171.6364.7271.9164.62145.5376.3365.949.6356.8338.2754.6970.787295.9942.83241.4750.11142.3455.33114.6259.959.9
Inventory21.51M23.19M22.47M26.21M27.68M16.5M10.54M474K220.51K114.8K89.5K52.88K69.68K29.7K39.21K51.75K44.22K0533.2K151.01K146.01K189.86K150.98K150.98K
Days Inventory Outstanding83.0190.8961.2471.780.1647.7990.7710.438.5877.144.849.194.889.0113.5712.39-356.35142.66301.19219.55110.29110.29
Other Current Assets5.55M8.42M11.57M10.08M9.32M000000288.96K0196.5K138.89K317.34K528.04K0100.48K201.47K0000
Total Non-Current Assets296M288.81M361.92M422.63M434.57M419.45M405.25M32.91M4.85M2.97M2.02M1.25M444.75K598.34K797.49K1.08M1.03M871.21K670.12K807.2K47.8K89.74K113.59K113.59K
Property, Plant & Equipment134.84M125.17M136.03M117.51M90.48M69.7M44.08M16.29M4.36M2.51M1.65M875.67K307.93K408.89K505.49K682.02K669.58K559.24K204.47K198.87K38.4K79.21K96.94K96.94K
Fixed Asset Turnover1.46x1.41x1.71x2.02x2.46x3.19x1.79x2.08x4.50x4.76x4.66x6.72x12.78x6.51x2.18x0.81x0.71x0.21x0.17x0.42x1.75x1.92x2.80x2.80x
Goodwill22.07M22.4M51.66M108.4M151.12M146.95M145.28M11M00000000-354.5M-311.65M000000
Intangible Assets135.99M138.08M170.46M194.38M191.01M201.43M213.91M5.18M137.22K90.65K5K13.48K136.82K180.09K272.26K379.08K354.85M311.96M278.52K1.2K9.39K10.53K16.65K16.65K
Long-Term Investments000000000000000000000000
Other Non-Current Assets2.04M2.09M2.9M1.68M1.02M950K1.98M437K350.84K363.4K363.4K363.4K09.36K19.74K19.74K9.36K0187.13K607.13K0000
Total Assets756.2M764.99M703.49M957.74M1.04B1.11B552.4M135.87M56.62M20.26M8.11M7.46M2.61M1.71M1.76M6.21M11.03M4.78M2.21M4.16M483.69K382.59K1.08M1.08M
Asset Turnover0.24x0.23x0.33x0.25x0.21x0.20x0.14x0.25x0.35x0.59x0.95x0.79x1.51x1.56x0.63x0.09x0.04x0.02x0.02x0.02x0.14x0.40x0.25x0.25x
Asset Growth %36.25%8.74%-26.55%-7.8%-6.67%101.48%306.56%139.97%179.41%149.81%8.76%186.14%52.44%-2.61%-71.74%-43.67%130.95%115.77%-46.77%759.88%26.43%-64.59%--
Total Current Liabilities221.04M219.02M64.56M45.61M40.85M42.65M35.02M5.46M3.06M2.19M2.23M2.47M3M4.01M2.5M1.11M3.24M1.91M3.52M1.48M914.29K670.6K607.96K607.96K
Accounts Payable015.28M26.17M26.05M27.05M28.58M24.84M2.5M1.64M1.2M1.16M758.7K758.7K579.68K858.71K401.4K506.89K823.65K331.96K234.82K306.68K174.16K162.99K162.99K
Days Payables Outstanding41.7159.971.3271.2978.3382.78214.0654.9663.9173.3592.5269.37100.195.18197.4105.22141.99418.88221.86221.83632.64201.39119.06119.06
Short-Term Debt4.54M185.26M14.44M149K60K00000651.93K981.99K1.51M2.98M1.4M433.9K2.17M440.39K2.88M856K285.44K54K24K24K
Deferred Revenue (Current)6.42M943K1.11M1.31M439K547K445K368K66.31K000000000000000
Other Current Liabilities214.77M3.35M3.71M3.8M3.45M1.91M1.39M518K056.27K0350.55K0020.85K0156.5K0000000
Current Ratio2.08x2.17x5.29x11.73x14.79x16.26x4.20x18.85x16.91x7.92x2.73x2.51x0.72x0.28x0.38x4.63x3.09x2.04x0.44x2.27x0.48x0.44x1.59x1.59x
Quick Ratio1.98x2.07x4.94x11.16x14.11x15.88x3.90x18.77x16.84x7.86x2.69x2.49x0.70x0.27x0.37x4.58x3.07x2.04x0.29x2.17x0.32x0.15x1.34x1.34x
Cash Conversion Cycle111.65100.161.5665.1473.7429.6322.2431.810.57-16.72-28.56-26.26-36.21-19.52-116.384.34-86.78-184.663.17-276.12132.7851.1351.13
Total Non-Current Liabilities229.32M43.33M237.03M423.11M442.06M428.5M134.69M4.13M15.01M192.2K200.26K026.45K01.32M1.38M1.85M3.78M2.37M1.74M1.86M1.67M1.65M1.65M
Long-Term Debt227.47M1.09M185.03M379.89M407.06M405.26M116.26M014.71M00026.45K01.32M1.38M421.73K2.3M2.37M1.74M1.66M35.44K43.44K43.44K
Capital Lease Obligations119.89M39.82M45.32M30.31M24.94M18.2M12.37M4.11M33.16K000000000000000
Deferred Tax Liabilities5.45M1.35M2.53M2.82M4.93M4.02M5.88M21K0000000000000000
Other Non-Current Liabilities01.07M4.14M10.1M5.13M1.03M176K0267.42K192.2K200.26K00000-1.42B1.48M0001.64M1.61M1.61M
Total Liabilities265.5M262.35M301.59M468.72M482.91M471.14M169.71M9.59M18.07M2.38M2.43M2.47M3.02M4.01M3.82M2.48M5.08M5.69M5.9M3.22M2.77M2.34M2.26M2.26M
Total Debt232.02M230.72M250.7M416M435.91M427.06M130.92M4.8M14.77M0651.93K981.99K1.54M2.98M2.72M1.81M3.34M4.22M5.25M2.59M2.14M89.44K67.44K67.44K
Net Debt-37.25M-19.78M205.41M369.66M399.31M287.95M94.05M-42.43M-22.56M-15.04M-4.6M-4.27M133.35K2.61M2.16M-4.28M-6.79M-1.04M4.47M-196.42K1.68M48.05K-652.75K-652.75K
Debt / Equity0.47x0.46x0.62x0.85x0.78x0.67x0.34x0.04x0.38x-0.11x0.20x---0.49x0.56x--2.75x----
Debt / EBITDA-13.16x---180.28x176.61x------------------
Net Debt / EBITDA2.11x---165.14x119.09x------------------
Interest Coverage-13.69x-12.63x-17.05x-4.71x-57.40x-57.40x-11.79x-12.37x-136.69x-502.02x-98.88x-8.21x-3.92x-23.94x-86.58x-13.84x-8.94x0.20x-5.20x-1.86x-9.18x-17.93x-11.07x-11.07x
Total Equity490.7M502.64M401.9M489.02M555.84M641.83M382.7M126.28M38.55M17.89M5.68M4.99M-416.3K-2.3M-2.06M3.73M5.95M-914.58K-3.68M943.99K-2.29M-1.96M-1.18M-1.18M
Equity Growth %94.85%25.07%-17.82%-12.02%-13.4%67.71%203.05%227.61%115.5%214.89%13.83%1298.72%81.94%-11.69%-155.32%-37.3%750.4%75.17%-490.22%141.26%-16.66%-66.19%--
Book Value per Share9.7310.048.259.9812.1013.979.923.781.370.780.400.63-0.08-0.53-0.611.445.01-2.04-10.002.68-8.28-7.35-7.38-7.38
Total Shareholders' Equity490.7M502.64M401.9M489.02M555.84M641.83M382.7M126.28M38.55M17.89M5.68M4.99M-416.3K-2.3M-2.06M3.73M5.95M-914.58K-3.68M943.99K-2.29M-1.96M-1.18M-1.18M
Common Stock51K50K50K49K48K50K40K37K30.32K25.7K17.6K7.25K5.03K5K37.76K37.76K27.5K8.14K41.3K39.98K34.78K29.94K29.71K29.71K
Retained Earnings-707.68M-688.88M-757.17M-642.42M-542.83M-467.54M-192.01M-159.32M-140.99M-131.43M-123.53M-109.35M-97.77M-85.88M-66.31M-59.93M-52.1M-45.94M-25.18M-11.96M-9.37M-6.69M-5.52M-5.52M
Treasury Stock000000000000000000000000
Accumulated OCI-2.45M-3.48M-20.93M-26.07M-34.55M-1.24M5.38M-45K3.15K00000000-253.37K-478.66K0-437.69K-337.1K00
Minority Interest000000000000000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Finite cash runway funded by equity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Fortified by Equity Injection

The balance sheet has undergone a dramatic transformation since 2024, with total debt cut by $182.9 million and equity expanding by $90.5 million, a recapitalization that appears to have been executed to provide a financial cushion for the company's operational challenges.

This shift, evidenced by the D/E ratio plummeting from 1.01 in 2024Q2 to 0.47 in 2026Q2, appears to be a strategic decision to prioritize balance sheet strength over near-term returns, likely to fund the ongoing capital expenditure surge and absorb operating losses. The trajectory represents a significant de-risking of the financial profile, but the source of this strength is investor capital rather than operational improvement, making its sustainability contingent on continued financing access.

Deleveraging Driven by Balance Sheet Restructuring

Total debt has been reduced by more than $182 million since its 2024 peak, bringing leverage to a manageable 0.47x debt-to-equity, a substantial deleveraging that appears to have been funded by equity proceeds rather than operating cash flow.

The significant reduction in financial obligations from $414.9 million in 2024Q1 to $232.0 million in 2026Q2 has materially improved the interest burden and financial flexibility. However, as the prior cash flow analysis indicates persistent negative operating cash flow, this deleveraging suggests a strategic choice to use capital raises for repayment. The improved leverage ratio is a positive for credit risk but does not yet reflect self-sustaining cash generation.

Cash Hoard Provides Critical Operating Runway

Liquidity has strengthened remarkably, with cash reserves surging from $36.1 million in 2025Q2 to $269.3 million by 2026Q2, creating a substantial buffer to fund operations and capital investments amid ongoing cash burn.

This $233 million increase in cash, resulting in a current ratio of 2.08x, appears to be the direct result of the equity financing activity, providing a necessary runway given the quarterly operating losses near $10 million and the sharply escalated capital expenditure. The buffer is significant but represents a finite resource, and its adequacy depends on the trajectory of the cash burn rate and the timeline to potential operational cash flow breakeven.

Equity Base Built on Financing, Not Retained Earnings

Book equity has grown to $490.7 million, yet this foundation is constructed entirely from external capital raises, as the accumulated deficit has deepened to -$707.7 million, signaling zero contribution from profitable operations to the equity base.

The vast negative retained earnings balance completely offsets the paid-in capital from financing, underscoring that shareholder equity is derived from investor funding. This dynamic means the company's net worth is a reflection of capital market access rather than operational performance; a sustained inability to generate profits would necessitate continued dilutive financing to maintain the balance sheet.

Asset Base Shifting from Goodwill to Physical Infrastructure

The composition of assets has evolved, with goodwill declining by $85.5 million to $22.1M, while net PPE has expanded by $17.8 million, indicating a strategic shift from intangible acquisition-driven assets to tangible operational capacity.

The significant reduction in goodwill suggests write-downs or impairments of prior acquisitions, which may signal integration challenges or a reassessment of acquisition valuations. Concurrently, the growth in net PPE aligns with the high CapEx intensity reported in the cash flow analysis, indicating a bet on building physical logistics infrastructure. This shift increases future depreciation charges but may be necessary to support the long-term operational model.

Finite Cash Buffer Masked by Strong Headline Liquidity

While the $269.3 million cash balance provides a strong current ratio, this buffer is likely funding a deep operational deficit and a CapEx cycle consuming 39% of revenue, suggesting the runway may be shorter than the headline figures imply.

The robust liquidity metrics are a direct result of a large equity raise, not operational generation. When viewed alongside the reported -$14.2 million quarterly free cash flow and a structural operating loss, the cash position appears to be drawing down to finance a high-investment phase. Investors should monitor the net burn rate and the pace at which capital expenditures translate into revenue-generating capacity to assess the true duration of this financial cushion.

CYRX — Frequently Asked Questions

Quick answers to the most common questions about buying CYRX stock.

What are the total assets of Cryoport, Inc. (CYRX)?

As of 2025, Cryoport, Inc. (CYRX) had total assets of $765.0M including $476.2M in current assets.

How much debt does Cryoport, Inc. (CYRX) have?

Cryoport, Inc. (CYRX) carries total debt of $230.7M, offset by $411.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cryoport, Inc.?

Cryoport, Inc. (CYRX) has total shareholders' equity (book value) of $502.6M ($10.04 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cryoport, Inc.'s current ratio and liquidity?

Cryoport, Inc. (CYRX) reported a current ratio of 2.17x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.